Ocrelizumab use in the real-world experience: data from a hot spot area for Multiple Sclerosis

被引：0
|
作者：
Mellino, P. [1 ]
Lorefice, L. [1 ]
Pilotto, S. [1 ]
Frau, J. [1 ]
Pintus, M. [1 ]
Barca, S. [1 ]
Coghe, G. [1 ]
Barracciu, M. [2 ]
Cocco, E. [1 ]
机构：
[1] Univ Cagliari, Multiple Sclerosis Ctr, Dept Med Sci & Publ Hlth, ASL Cagliari,Binaghi Hosp, Cagliari, Italy
[2] ASL Cagliari, Binaghi Hosp, Radiol Unit, Cagliari, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-497
引用
收藏
页码：634 / 635
页数：2
相关论文
共 50 条
  • [1] Findings from a large monocentric real-world experience of Ocrelizumab use in Multiple Sclerosis
    Mellino, Paolo
    Pilotto, Silvy
    Frau, Jessica
    Carmagnini, Daniele
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 613 - 614
  • [2] Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario
    Lorefice, Lorena
    Mellino, Paolo
    Frau, Jessica
    Coghe, Giancarlo
    Fenu, Giuseppe
    Cocco, Eleonora
    NEUROLOGICAL SCIENCES, 2024, 45 (08) : 3951 - 3959
  • [3] Real-world experience of ocrelizumab in multiple sclerosis in an Arab population
    Garcia-Canibano, Beatriz
    Ouanes, Sami
    Ganesan, Gowrii Saswathy
    Yousuf, Wajiha
    Humos, Basel
    Baig, Tehniyat
    Ibrahim, Faiza
    Singh, Rajvir
    Deleu, Dirk
    JOURNAL OF DRUG ASSESSMENT, 2021, 10 (01) : 106 - 113
  • [4] Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population
    Fernandez-Diaz, Eva
    Perez-Vicente, Jose A.
    Villaverde-Gonzalez, Ramon
    Berenguer-Ruiz, Leticia
    Candeliere Merlicco, Antonio
    Martinez-Navarro, Maria Luisa
    Gracia Gil, Julia
    Romero-Sanchez, Carlos M.
    Alfaro-Saez, Arantxa
    Diaz, Inmaculada
    Gimenez-Martinez, Juana
    Mendez-Miralles, Maria Angeles
    Millan-Pascual, Jorge
    Jimenez-Pancho, Javier
    Mola, Santiago
    Sempere, Angel P.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (02): : 385 - 394
  • [5] Switching from ocrelizumab to ofatumumab in multiple sclerosis: a monocenter real-world experience
    Axhausen, Franziska
    Baumgart, Romy
    Winter, Pia
    Mueck, Anna
    Huttner, Hagen
    Wolff, Stephanie
    Pfeuffer, Steffen
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1100
  • [6] Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Fruns, Manuel
    Hornung, Giesela
    Flores, Jose
    Carnero Contentti, Edgar
    Adrian Lopez, Pablo
    Pablo Pettinicchi, Juan
    Caride, Alejandro
    Galleguillos, Lorna
    Barahona, Jorge
    Diaz, Violeta
    Hernandez, Marianella
    Alonso, Ricardo
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (04) : 305 - 309
  • [7] Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population
    Coban, Hamza
    Germaine, Sarah
    Dimaandal, Ian
    Haberli, Nicholas
    Padam, Charanpreet
    Creed, Marina A.
    Imitola, Jaime
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [8] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [9] Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain
    Sempere, Angel P.
    Berenguer-Ruiz, Leticia
    Borrego-Soriano, Ines
    Burgos-San Jose, Amparo
    Concepcion-Aramendia, Luis
    Volar, Lucian
    Aragones, Miguel
    Palazon-Bru, Antonio
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [10] A Real World Data of Ocrelizumab in Multiple Sclerosis
    Beckmann, Y.
    Uzunkopru, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 671 - 671
12345